Impact of Platelet Volume on the Clinical Outcomes of Patients with Acute Coronary Syndrome

Impact of Platelet Volume on the Clinical Outcomes of Patients with Acute Coronary Syndrome

Background: Platelets with high hemostatic activity play an important role in the pathophysiology of acute coronary syndrome (ACS), and mean platelet volume (MPV) has been proposed to be an indicator of platelet reactivity. We evaluated the predictive value of MPV and the responsive value of MPV wit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta Cardiologica Sinica 2019-11, Vol.35 (6), p.563-570
Hauptverfasser: Hsien-Yuan Chang, Ling-Wei Hsu, Cheng-Han Lee, Chih-Chan Lin, Chen-Wei Huang, Po-Wei Chen, Po-Kai Yang, Yang-Che Hsueh, Ping-Yen Liu
Format: Artikel
Sprache:chi
Schlagworte:
ACS
Acute coronary syndrome
Mean platelet volume
MEDLINE
MPV
SCIE
Scopus
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 570
container_issue 6
container_start_page 563
container_title Acta Cardiologica Sinica
container_volume 35
creator Hsien-Yuan Chang
Ling-Wei Hsu
Cheng-Han Lee
Chih-Chan Lin
Chen-Wei Huang
Po-Wei Chen
Po-Kai Yang
Yang-Che Hsueh
Ping-Yen Liu
description Background: Platelets with high hemostatic activity play an important role in the pathophysiology of acute coronary syndrome (ACS), and mean platelet volume (MPV) has been proposed to be an indicator of platelet reactivity. We evaluated the predictive value of MPV and the responsive value of MPV with different antiplatelet agents in association with the clinical outcomes of ACS patients. Methods: A total of 1094 patients with ACS and 472 patients without ACSwere included. Blood sampleswere taken at hospital admission, at routine follow-up within one year, and beyond one year. The patients were divided into a “high MPV group” (＞ 9.0 fl, n = 305), “medium MPV group” (7.9-9.0 fl, n = 517), and “low MPV group” (＜ 7.9 fl, n = 272). The average follow-up time was 2.4 years, and the endpoints were major adverse cardiovascular events (MACEs) including all-cause mortality, time to recurrent ACS, target vessel re-intervention and stroke. Results: MPV was significantly higher in the patients with ACS than in those witho
format Article
fullrecord <record><control><sourceid>hyweb</sourceid><recordid>TN_cdi_hyweb_hyread_00544983</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>00544983</sourcerecordid><originalsourceid>FETCH-hyweb_hyread_005449833</originalsourceid><addsrcrecordid>eNqFyr0KwjAUQOEMChbtGzjcFyikv7ajFEUnBcXFoaTtLQ2kiSS3lL69Iu5OZzjfgnkhD8Mgy5NoxXznZM3DLI2KlO889jwPL9EQmA6uShAqJHgYNQ4IRgP1CKWSWjZCwWWkxgzovlaQRE0OJkk97JuRPtBYo4Wd4Tbr1n7khi07oRz6v67Z9ni4l6egnyesq362KNqK8zRJijyO_-w3oEo9Ww</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Impact of Platelet Volume on the Clinical Outcomes of Patients with Acute Coronary Syndrome</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Hsien-Yuan Chang ; Ling-Wei Hsu ; Cheng-Han Lee ; Chih-Chan Lin ; Chen-Wei Huang ; Po-Wei Chen ; Po-Kai Yang ; Yang-Che Hsueh ; Ping-Yen Liu</creator><creatorcontrib>Hsien-Yuan Chang ; Ling-Wei Hsu ; Cheng-Han Lee ; Chih-Chan Lin ; Chen-Wei Huang ; Po-Wei Chen ; Po-Kai Yang ; Yang-Che Hsueh ; Ping-Yen Liu</creatorcontrib><description>Background: Platelets with high hemostatic activity play an important role in the pathophysiology of acute coronary syndrome (ACS), and mean platelet volume (MPV) has been proposed to be an indicator of platelet reactivity. We evaluated the predictive value of MPV and the responsive value of MPV with different antiplatelet agents in association with the clinical outcomes of ACS patients. Methods: A total of 1094 patients with ACS and 472 patients without ACSwere included. Blood sampleswere taken at hospital admission, at routine follow-up within one year, and beyond one year. The patients were divided into a “high MPV group” (＞ 9.0 fl, n = 305), “medium MPV group” (7.9-9.0 fl, n = 517), and “low MPV group” (＜ 7.9 fl, n = 272). The average follow-up time was 2.4 years, and the endpoints were major adverse cardiovascular events (MACEs) including all-cause mortality, time to recurrent ACS, target vessel re-intervention and stroke. Results: MPV was significantly higher in the patients with ACS than in those witho</description><identifier>ISSN: 1011-6842</identifier><language>chi</language><publisher>台灣: 中華民國心臟學會</publisher><subject>ACS ; Acute coronary syndrome ; Mean platelet volume ; MEDLINE ; MPV ; SCIE ; Scopus</subject><ispartof>Acta Cardiologica Sinica, 2019-11, Vol.35 (6), p.563-570</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785</link.rule.ids></links><search><creatorcontrib>Hsien-Yuan Chang</creatorcontrib><creatorcontrib>Ling-Wei Hsu</creatorcontrib><creatorcontrib>Cheng-Han Lee</creatorcontrib><creatorcontrib>Chih-Chan Lin</creatorcontrib><creatorcontrib>Chen-Wei Huang</creatorcontrib><creatorcontrib>Po-Wei Chen</creatorcontrib><creatorcontrib>Po-Kai Yang</creatorcontrib><creatorcontrib>Yang-Che Hsueh</creatorcontrib><creatorcontrib>Ping-Yen Liu</creatorcontrib><title>Impact of Platelet Volume on the Clinical Outcomes of Patients with Acute Coronary Syndrome</title><title>Acta Cardiologica Sinica</title><description>Background: Platelets with high hemostatic activity play an important role in the pathophysiology of acute coronary syndrome (ACS), and mean platelet volume (MPV) has been proposed to be an indicator of platelet reactivity. We evaluated the predictive value of MPV and the responsive value of MPV with different antiplatelet agents in association with the clinical outcomes of ACS patients. Methods: A total of 1094 patients with ACS and 472 patients without ACSwere included. Blood sampleswere taken at hospital admission, at routine follow-up within one year, and beyond one year. The patients were divided into a “high MPV group” (＞ 9.0 fl, n = 305), “medium MPV group” (7.9-9.0 fl, n = 517), and “low MPV group” (＜ 7.9 fl, n = 272). The average follow-up time was 2.4 years, and the endpoints were major adverse cardiovascular events (MACEs) including all-cause mortality, time to recurrent ACS, target vessel re-intervention and stroke. Results: MPV was significantly higher in the patients with ACS than in those witho</description><subject>ACS</subject><subject>Acute coronary syndrome</subject><subject>Mean platelet volume</subject><subject>MEDLINE</subject><subject>MPV</subject><subject>SCIE</subject><subject>Scopus</subject><issn>1011-6842</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNqFyr0KwjAUQOEMChbtGzjcFyikv7ajFEUnBcXFoaTtLQ2kiSS3lL69Iu5OZzjfgnkhD8Mgy5NoxXznZM3DLI2KlO889jwPL9EQmA6uShAqJHgYNQ4IRgP1CKWSWjZCwWWkxgzovlaQRE0OJkk97JuRPtBYo4Wd4Tbr1n7khi07oRz6v67Z9ni4l6egnyesq362KNqK8zRJijyO_-w3oEo9Ww</recordid><startdate>201911</startdate><enddate>201911</enddate><creator>Hsien-Yuan Chang</creator><creator>Ling-Wei Hsu</creator><creator>Cheng-Han Lee</creator><creator>Chih-Chan Lin</creator><creator>Chen-Wei Huang</creator><creator>Po-Wei Chen</creator><creator>Po-Kai Yang</creator><creator>Yang-Che Hsueh</creator><creator>Ping-Yen Liu</creator><general>中華民國心臟學會</general><scope>9RA</scope></search><sort><creationdate>201911</creationdate><title>Impact of Platelet Volume on the Clinical Outcomes of Patients with Acute Coronary Syndrome</title><author>Hsien-Yuan Chang ; Ling-Wei Hsu ; Cheng-Han Lee ; Chih-Chan Lin ; Chen-Wei Huang ; Po-Wei Chen ; Po-Kai Yang ; Yang-Che Hsueh ; Ping-Yen Liu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-hyweb_hyread_005449833</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>chi</language><creationdate>2019</creationdate><topic>ACS</topic><topic>Acute coronary syndrome</topic><topic>Mean platelet volume</topic><topic>MEDLINE</topic><topic>MPV</topic><topic>SCIE</topic><topic>Scopus</topic><toplevel>online_resources</toplevel><creatorcontrib>Hsien-Yuan Chang</creatorcontrib><creatorcontrib>Ling-Wei Hsu</creatorcontrib><creatorcontrib>Cheng-Han Lee</creatorcontrib><creatorcontrib>Chih-Chan Lin</creatorcontrib><creatorcontrib>Chen-Wei Huang</creatorcontrib><creatorcontrib>Po-Wei Chen</creatorcontrib><creatorcontrib>Po-Kai Yang</creatorcontrib><creatorcontrib>Yang-Che Hsueh</creatorcontrib><creatorcontrib>Ping-Yen Liu</creatorcontrib><collection>HyRead台灣全文資料庫</collection><jtitle>Acta Cardiologica Sinica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hsien-Yuan Chang</au><au>Ling-Wei Hsu</au><au>Cheng-Han Lee</au><au>Chih-Chan Lin</au><au>Chen-Wei Huang</au><au>Po-Wei Chen</au><au>Po-Kai Yang</au><au>Yang-Che Hsueh</au><au>Ping-Yen Liu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of Platelet Volume on the Clinical Outcomes of Patients with Acute Coronary Syndrome</atitle><jtitle>Acta Cardiologica Sinica</jtitle><date>2019-11</date><risdate>2019</risdate><volume>35</volume><issue>6</issue><spage>563</spage><epage>570</epage><pages>563-570</pages><issn>1011-6842</issn><abstract>Background: Platelets with high hemostatic activity play an important role in the pathophysiology of acute coronary syndrome (ACS), and mean platelet volume (MPV) has been proposed to be an indicator of platelet reactivity. We evaluated the predictive value of MPV and the responsive value of MPV with different antiplatelet agents in association with the clinical outcomes of ACS patients. Methods: A total of 1094 patients with ACS and 472 patients without ACSwere included. Blood sampleswere taken at hospital admission, at routine follow-up within one year, and beyond one year. The patients were divided into a “high MPV group” (＞ 9.0 fl, n = 305), “medium MPV group” (7.9-9.0 fl, n = 517), and “low MPV group” (＜ 7.9 fl, n = 272). The average follow-up time was 2.4 years, and the endpoints were major adverse cardiovascular events (MACEs) including all-cause mortality, time to recurrent ACS, target vessel re-intervention and stroke. Results: MPV was significantly higher in the patients with ACS than in those witho</abstract><cop>台灣</cop><pub>中華民國心臟學會</pub></addata></record>
fulltext fulltext
identifier ISSN: 1011-6842
ispartof Acta Cardiologica Sinica, 2019-11, Vol.35 (6), p.563-570
issn 1011-6842
language chi
recordid cdi_hyweb_hyread_00544983
source EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects ACS
Acute coronary syndrome
Mean platelet volume
MEDLINE
MPV
SCIE
Scopus
title Impact of Platelet Volume on the Clinical Outcomes of Patients with Acute Coronary Syndrome
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T09%3A00%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-hyweb&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20Platelet%20Volume%20on%20the%20Clinical%20Outcomes%20of%20Patients%20with%20Acute%20Coronary%20Syndrome&rft.jtitle=Acta%20Cardiologica%20Sinica&rft.au=Hsien-Yuan%20Chang&rft.date=2019-11&rft.volume=35&rft.issue=6&rft.spage=563&rft.epage=570&rft.pages=563-570&rft.issn=1011-6842&rft_id=info:doi/&rft_dat=%3Chyweb%3E00544983%3C/hyweb%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true